Medical and lifestyle interventions successfully lowered the risk of type 2 diabetes in women with a history of gestational diabetes.
Women with gestational diabetes mellitus could benefit from medical and lifestyle interventions aimed at reducing the chances of later development of type 2 diabetes mellitus, researchers found.
Women with a history of gestational diabetes are at increased risk for type 2 diabetes. However, that risk can be lowered with proper use of preventative medicine and intensive lifestyle intervention, the authors of a long-term study concluded.
- Both an intensive lifestyle intervention and the drug metformin effectively slowed the progression to type 2 diabetes in women with a history of gestational diabetes.
- It was estimated that 7 women with a history of gestational diabetes mellitus would need to be treated to prevent 1 case of diabetes over 10 years.
The Diabetes Prevention Program Outcomes Study analyzed the long-term metabolic health in 288 women who had a previous diagnosis of gestational diabetes and 1226 mothers who did not have a history of the condition. The randomized trial assigned the women to intensive lifestyle intervention, the diabetes medication metformin, or a placebo. The lifestyle intervention sought to guide the women to reduce their body weight by 7% and participate in moderate cardiovascular exercise for 150 minutes a week. Blood glucose levels were measured twice a year for 6 years.
During a 10-year span, women with a history of gestational diabetes who were assigned to placebo had a 48% higher risk of diabetes developing compared with women who did not have a history of gestational diabetes.
Among women who had had gestational diabetes and underwent intensive lifestyle intervention, the risk of developing type 2 diabetes was reduced by 35%. In women with a history of gestational diabetes who were assigned to take metformin, the risk was reduced by 40%.
"Medical and lifestyle interventions were remarkably effective at slowing the progression of type 2 diabetes in this at-risk population in both the short and long term," said author Vanita Aroda, MD, of the MedStar Health Research Institute in Hyattsville, MD.
The authors estimated that 7 women with a history of gestational diabetes would have to be treated with metformin and lifestyle to prevent 1 case of diabetes over 10 years.
The study was published online in the Journal of Clinical Endocrinology & Metabolism.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More